"The auto industry remains cautiously optimistic about its...
Category:
Eco/Invest/Demography
Latest
Global health heavyweights team up for climate, disease funding
The Novo Nordisk Foundation, Wellcome and the Bill & Melinda...
Consumer affairs ministry to meet e-commerce firms on May 15 to curb fake online reviews
The draft Quality Control Order(QCO) of Consumer Affairs Ministry...
Vaccine airlift delivers shot in the arm for airlines
IATA, representing 290 airlines, warns that vaccine rollout could be “compromised” without an easing of the travel curbs and quarantines it has lobbied against.
“There are parts of the world that have no cargo operations once the passenger networks are grounded,” IATA head of cargo Glyn Hughes said.
Sensex, Nifty end at record high on consumer goods boost
In the latest development on the domestic front, Serum Institute of India, the world’s largest producer of vaccines by volume and India’s main hope for large-scale supplies, said it had made the first formal application for emergency use approval for AstraZeneca COVID-19 vaccine.
India considering accelerated review of COVID-19 vaccine emergency use
“We are in the process of reviewing. It is an accelerated reviewing process, which is there for Serum too,” the government official said. “All applications are accelerated. It is the need of the hour.”
Centre sends countrywide advisory for ‘Bharat Bandh’
In a countrywide advisory, the Union Home Ministry also said the state governments and UT administrations must ensure that the Covid-19 guidelines issued with regard to health and social distancing are strictly followed.
Cyber insurance shifting into personal lines as consumer interest rises in UK:GlobalData
Daniel Pearce, Senior Insurance Analyst at GlobalData, comments: “The need for cyber insurance policies has long been identified in the commercial space, where reliance on technology for day-to-day business activities has grown at an exponential rate. However, individuals have also become increasingly dependent on technology. With their exposure to cyber risks growing, the personal cyber insurance market is burgeoning.”
Country will not have to wait too long for COVID-19 Vaccine:PM Modi
“However, there should be no laxity from our side as far as prevention of the infection is concerned. Masks and a distance of two yards is very necessary,” Modi said.
4 of 5 cyclones this year were in severe cyclonic storms category and above
India Meteorological Department (IMD) Director General Mrutunjay Mohapatra said since 1990 four cyclones have formed every year in the seas along the eastern and western coasts (Bay of Bengal and Arabian Sea) of the country.
“It is normal to have five cyclones a year,” he said.
Value Of LIC’s equity holdings rallies 40% in h1 to Rs 5.7 lakh crore
As against this, domestic institutional investors’ holdings in the BSE-200 Index slipped to 13.6 percent in Q2 from 14 percent in Q1, as they sold shares worth Rs 63,500 crore since April. As of July-September, the value of LIC’s holdings in top 200 stocks stood at $77 billion.
During the first half of FY2021, value of LIC’s holding surged over 40 percent, or by $22 billion to $77 billion and LIC is said to have pumped Rs 55,000 crore into the equity market since April, as against Rs 32,800 crore in the year-ago period.
Approval from IRDAI on Axis Bank stake hike expected by March: Max Life CEO
“Under the revised agreements, Axis Bank will acquire up to 9.002 percent of the equity share capital of Max Life, and Axis Capital Limited and Axis Securities Limited will together acquire up to 3 percent of the share capital of Max Life.
“In addition, Axis entities will have a right to acquire an additional stake of up to 7 percent of the equity share capital of Max Life, in one or more tranches, in accordance with existing laws and regulations,” the bank had said.
India should begin scaling up syringe stocks for Covid vaccination: Experts
According to Rajiv Nath, Managing Director of Hindustan Syringes & Medical Devices Ltd, the estimated demand in India would be around 900 million pieces of different kinds of syringes for just one shot of the vaccine, considering 60-70 per cent of the country gets vaccinated.
“The number would amplify to 1.8 billion if the vaccine India chooses needs two shots,” Nath told IANS.